Cytosorbents Corporation

Total Valuation

Cytosorbents Corporation carries a market capitalization of 24.00M, placing it among publicly traded companies globally. Its enterprise value stands at 59.98M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Cytosorbents Corporation currently has 62.73M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 0.95, and the price-to-book ratio stands at -0.11.

Enterprise Valuation

Financial Position

Cytosorbents Corporation maintains a current ratio of 1.09, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1,334.37, indicating moderate leverage, while an interest coverage ratio of -4.12 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Cytosorbents Corporation's stock has declined approximately -62.55882% over the past 52 weeks. The 50-day moving average sits at 0.44, while the 200-day moving average is 0.64.

Income Statement

Over the trailing twelve months, Cytosorbents Corporation generated 37.20M in revenue and converted that into -11.85M in net income, yielding earnings per share of -0.19. EBITDA reached -11.79M, while operating income came in at -13.40M.

Balance Sheet

Cytosorbents Corporation holds 4.81M in cash and equivalents against 29.28M in total debt, resulting in a net debt position of 12.15M. Total book value stands at -317.27M, with working capital of 1.45M providing operational flexibility.

Cash Flow

Cytosorbents Corporation produced -10.07M in operating cash flow over the past twelve months. After subtracting -516,000.00 in capital expenditures, free cash flow totaled -10.59M - equivalent to -0.17 per share.

Margins

Cytosorbents Corporation operates with a gross margin of 71.01, reflecting its pricing power and cost economics. The operating margin of -36.01 and net profit margin of -31.85 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Cytosorbents Corporation's most recent stock split took place on December 5, 2014 with a 25:1 split ratio.

Scores

Cytosorbents Corporation posts an Altman Z-Score of -11.40, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.